Telcare, Inc. uses cellular technology and social networking to bridge the last mile between patients with diabetes, their caregivers, and their families in order to transform the care of chronic illness. The company's first product, a wireless Blood Glucose Monitoring System, was launched in February 2012.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/22/12 | $25,500,000 | Series B |
Qualcomm Ventures | undisclosed |
